Hyaluronic acid-based hydrogel induces neovascularization and improves cardiac function in a rat model of myocardial infarction
Open Access
- 12 July 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (5) , 767-772
Abstract
The use of stem cells in cardiac regeneration is still limited due to low cellular integration and engraftment rates. Consequently, there has been a spurt in research on developing alternative regenerative therapies. Hyaluronic acid (HA) is a major component of the extracellular matrix that is non-immunogenic, and has been implicated in various wound-healing functions such as angiogenesis and inflammation modulation, making it an ideal candidate for regenerative biomaterials. In this study, we examine the potential of acellular hyaluronic acid-based hydrogel in improving cardiac function post-myocardial infarction in a rat model. Hyaluronic acid-based hydrogel was injected into the peri-infarct region post-myocardial infarction induction in Lewis rats. Cardiac function in control (n = 10) and gel-injected groups (n = 10) was evaluated up to 4 weeks post-myocardial infarction. Evaluation of cardiac function was conducted using transthoracic echocardiography. Histological analysis of scar area was evaluated via haematoxylin and eosin (H & E), and Sirius red staining. Neovascularization was detected using vascular endothelial growth factor (VEGF) staining. Evaluation of cardiac function using transthoracic echocardiography revealed a 18.2% (P < 0.01) increase in ejection fraction in gel-injected groups when compared with the control group, almost returning the ejection fraction to baseline levels (preop). Histological analysis of scar area by haematoxylin and eosin (H&E), and Sirius red staining demonstrated decreased scarring, and a 22.6% (P < 0.01) decrease in collagen deposition in the gel-injected group compared with the control group. VEGF staining indicated a significant increase in novel vasculature formation in hydrogel-injected groups when compared with control. Due to its regenerative potential, hyaluronic acid-based hydrogel provides a promising novel therapy to be used alone, or as a scaffold delivering a variety of drugs or cells to combat heart disease in a multifaceted approach.Keywords
This publication has 23 references indexed in Scilit:
- Characterization and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor CellsPLOS ONE, 2012
- Regeneration of ischemic heart using hyaluronic acid‐based injectable hydrogelJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2009
- Intracoronary Bone Marrow Cell Transfer After Myocardial InfarctionCirculation, 2006
- Hyaluronan: from extracellular glue to pericellular cueNature Reviews Cancer, 2004
- Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarctsNature, 2004
- A Different Outlook on the Role of Bone Marrow Stem Cells in Vascular GrowthCirculation Research, 2004
- Angiogenic Oligosaccharides of Hyaluronan Induce Multiple Signaling Pathways Affecting Vascular Endothelial Cell Mitogenic and Wound Healing ResponsesJournal of Biological Chemistry, 2002
- Mechanisms and Models in Heart FailureCirculation, 1999
- Retention of hyaluronic acid in alginate beads: Aspects forin vitro cartilage engineeringJournal of Biomedical Materials Research, 1999
- Hyaluronic acid stimulates human fibroblast proliferation within a collagen matrixJournal of Cellular Physiology, 1998